ArticleBreast cancer research and treatment2025
Preferences of patients with high-risk HR + /HER2- breast cancer for adjuvant endocrine treatment: an adaptive choice-based conjoint analysis study from Germany.
Achim Wöckel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.